Invesaro

Stocks Comparison

Boston Scientific vs 3M: revenue, profit, margins and growth compared

Boston Scientific brought in $20.1B of revenue in fiscal 2025, 3M $24.9B in fiscal 2025. Revenue changed by +19.9% at Boston Scientific and +1.5% at 3M on the year before, so Boston Scientific grew faster. Boston Scientific kept 14.4% of its revenue as net profit, 3M 13.0%. Free cash flow was $3.7B at Boston Scientific and $1.4B at 3M.

Side by side, latest fiscal year

BSXMMM
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$20.1B$24.9B
Revenue growth+19.9%+1.5%
Net income$2.9B$3.3B
Net margin14.4%13.0%
Free cash flow$3.7B$1.4B
Free cash flow margin18.2%5.6%
Earnings per share (diluted)$1.94$6.00
Cash$2B$5.2B
Debt$11.1B$12.6B
Price to earnings22.628.3
Market value$63.7B$87.4B
Dividend yieldn/a1.72%
Rank by revenue in sector#30 of 523 · Health care#25 of 523 · Health care

Over the years

Revenue
BSX FY2018: $9.8BBSX FY2019: $10.7BBSX FY2020: $9.9BBSX FY2021: $11.9BBSX FY2022: $12.7BBSX FY2023: $14.2BBSX FY2024: $16.7BBSX FY2025: $20.1BMMM FY2018: $32.8BMMM FY2019: $32.1BMMM FY2020: $32.2BMMM FY2021: $35.4BMMM FY2022: $26.2BMMM FY2023: $24.6BMMM FY2024: $24.6BMMM FY2025: $24.9BFY18FY19FY20FY21FY22FY23FY24FY25
BSX $20.1BMMM $24.9B
Net income
BSX FY2018: $1.7BBSX FY2019: $4.7BBSX FY2020: -$115MBSX FY2021: $985MBSX FY2022: $642MBSX FY2023: $1.6BBSX FY2024: $1.9BBSX FY2025: $2.9BMMM FY2018: $5.3BMMM FY2019: $4.5BMMM FY2020: $5.4BMMM FY2021: $5.9BMMM FY2022: $5.8BMMM FY2023: -$7BMMM FY2024: $4.2BMMM FY2025: $3.3BFY18FY19FY20FY21FY22FY23FY24FY25
BSX $2.9BMMM $3.3B
Net margin
BSX FY2018: 17.0%BSX FY2019: 43.8%BSX FY2020: -1.2%BSX FY2021: 8.3%BSX FY2022: 5.1%BSX FY2023: 11.0%BSX FY2024: 11.1%BSX FY2025: 14.4%MMM FY2018: 16.3%MMM FY2019: 14.1%MMM FY2020: 16.9%MMM FY2021: 16.7%MMM FY2022: 22.1%MMM FY2023: -28.4%MMM FY2024: 17.0%MMM FY2025: 13.0%FY18FY19FY20FY21FY22FY23FY24FY25
BSX 14.4%MMM 13.0%
Revenue growth
BSX FY2019: +9.3%BSX FY2020: -7.7%BSX FY2021: +19.9%BSX FY2022: +6.7%BSX FY2023: +12.3%BSX FY2024: +17.6%BSX FY2025: +19.9%MMM FY2019: -1.9%MMM FY2020: +0.1%MMM FY2021: +9.9%MMM FY2022: -26.0%MMM FY2023: -5.9%MMM FY2024: -0.1%MMM FY2025: +1.5%FY19FY20FY21FY22FY23FY24FY25
BSX +19.9%MMM +1.5%
Free cash flow
BSX FY2018: -$6MBSX FY2019: $1.4BBSX FY2020: $1.1BBSX FY2021: $1.3BBSX FY2022: $938MBSX FY2023: $1.8BBSX FY2024: $2.6BBSX FY2025: $3.7BMMM FY2018: $4.9BMMM FY2019: $5.4BMMM FY2020: $6.6BMMM FY2021: $5.9BMMM FY2022: $3.8BMMM FY2023: $5.1BMMM FY2024: $638MMMM FY2025: $1.4BFY18FY19FY20FY21FY22FY23FY24FY25
BSX $3.7BMMM $1.4B

Fiscal years as each company reports them; the two may end in different months.

Questions about Boston Scientific and 3M

Which is bigger by revenue, Boston Scientific or 3M?

3M is bigger by revenue: $24.9B in fiscal 2025, against $20.1B for Boston Scientific in fiscal 2025.

Which keeps more of its revenue as profit, Boston Scientific or 3M?

Boston Scientific had a net margin of 14.4% in fiscal 2025; 3M had 13.0% in fiscal 2025.

Which grew revenue faster, Boston Scientific or 3M?

In their latest fiscal years revenue changed by +19.9% at Boston Scientific and +1.5% at 3M.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies